Via application of specialized range of in-vitro, ex-vivo and in-vivo tests, GlioCure offers a complete solution for the detection and selection of molecules of interest in neuro-oncology. Gliocure can then conduct pharmacological and pharmaceutical development of these molecules to make it into drug candidates suitable for entering the clinical development phase.
From discovery to clinical trial authorization :
Define and validate the right target product profile
